Principal Scientist, Analytical Development jobs in United States
cer-icon
Apply on Employer Site
company-logo

Praxis Precision Medicines, Inc. · 20 hours ago

Principal Scientist, Analytical Development

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders. The Principal Scientist in Analytical Development will lead the analytical function, ensuring efficient and controlled processes while collaborating with various teams to support the clinical and commercial pipeline.

Alternative MedicineBiotechnologyHealth CareMedicalPrecision Medicine
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Involved in all analytical deliverables with CMC program while acting as Analytical lead, including management and execution of analytical testing and for the Analytical Development team and our external network, especially as it relates to method development, validation and GMP testing. This includes technical troubleshooting, data interpretation, reviewing method validation documents, authoring CoA-s, stability reports
Direct management of our external network providers that execute Analytical Development activities to ensure deliverables and continuously improve on efficiency
Leading the design and development of phase-appropriate quality control strategies, specifications, and stability studies for drug substance and drug product
Contribute to the overall CMC team in terms of execution but also development of our CMC operations function, process improvement
Collaborate with other functions of Praxis CMC to establish the technical and business practices of the team

Qualification

Analytical ChemistryAnalytical DevelopmentCGMP requirementsOligonucleotide experienceCMC developmentInterpersonal skillsProblem solvingDetail-oriented

Required

Advanced degree (PhD or Masters degree with related experience) in Analytical Chemistry or related discipline with 5-7 years of industry experience
Industry experience in Analytical Development specifically for small molecule drug substance and solid oral drug products is required
Strong knowledge of US and EU cGMP requirements and best practices relating to drug substances and drug products
Ability to interpret and implement, as appropriate, compendia-based testing requirements for drug substances and drug products
Involvement in reference standard management and stability oversight
Demonstrated success in building and maintaining productive partnerships with third-party CRO /CMO partners and associated service providers to develop and manufacturing pharmaceutical products
Fluid and conversant with GMP and quality control
Demonstrates a high level of intellectual curiosity, innovation and creative problem solving with an entrepreneurial spirit; can thrive in an agile environment
Excellent interpersonal and communication skills, with the ability to develop important relationships that include trust and encourage diversity in all its forms
Highly organized and detail-oriented with a passion to deliver quality results
The physical and mental requirements of our roles include but are not limited to regular use of a computer, devices or other office equipment, clear communication, and occasional movement

Preferred

Preferred with biopharmaceutical innovator or CMO
Experience with oligonucleotide drug substance and/or drug products desirable
Experience with CMC development and support across all phases of drug development from initial regulatory filings through registration, validation and launch preferred
Experience in support of late-stage / commercial products including product monitoring, improvement and issue resolution preferred

Benefits

99% of the premium paid for medical, dental and vision plans
Company-paid life insurance
AD&D
Disability benefits
Voluntary plans to personalize your coverage
Match dollar-for-dollar up to 6% on eligible 401(k) contributions
Long-term stock incentives
ESPP
Discretionary quarterly bonus
Flexible wellness benefit
Generous PTO
Paid holidays
Company-wide shutdowns

Company

Praxis Precision Medicines, Inc.

twittertwittertwitter
company-logo
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders characterized by neuronal imbalance.

H1B Sponsorship

Praxis Precision Medicines, Inc. has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (1)

Funding

Current Stage
Public Company
Total Funding
$1.67B
Key Investors
Eventide
2026-01-06Post Ipo Equity· $575M
2025-10-16Post Ipo Equity· $525M
2024-03-28Post Ipo Equity· $200M

Leadership Team

leader-logo
Marcio Souza
President and CEO
linkedin
leader-logo
Tim Kelly
Chief Financial Officer
linkedin
Company data provided by crunchbase